RxDoctor Payments Data

Cheri Fogle

Family · Greenville, KYNPI 1518959923

Payments from drug & device makers

$1,486in general payments, 2019–2025

Across 88 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$266
  • Lilly USA, LLC$193
  • AbbVie$186
  • Bayer$109
  • Pfizer$102
  • Xeris Pharmaceuticals, Inc.$81
  • plus $550 from 15 others

What the payments were for

  • Food & beverage$1,42096%
  • Education$664%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,486 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$5,881
Medicare patients
66
Services billed
492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide127$138,278
Humira(Cf) PenAdalimumab13$102,569
TrulicityDulaglutide23$43,588
EliquisApixaban59$40,476
JardianceEmpagliflozin50$37,113
MounjaroTirzepatide30$32,914
JanuviaSitagliptin Phosphate29$21,320
TradjentaLinagliptin17$10,745
SymbicortBudesonide/Formoterol Fumarate38$9,767
Repatha SureclickEvolocumab12$6,567
Tresiba Flextouch U-100Insulin Degludec13$6,260
Ondansetron Hcl52$5,648
Albuterol Sulfate HfaAlbuterol Sulfate126$4,279
Esomeprazole Magnesium135$3,434
Atorvastatin Calcium442$2,637

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$266$138,278127 claims
Lilly USA, LLCTrulicity, Mounjaro, Humulin 70-30$193$78,41665 claims
Boehringer IngelheimJardiance, Tradjenta$35$47,85867 claims
PfizerEliquis$102$40,47659 claims
AstraZenecaSymbicort$57$9,76738 claims
AbbVieSynthroid$186$1,00529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Greenville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →